The PCSK9 monoclonal shot targets the PCSK9 protein. Basically, the more PCSK9 the body makes, the higher the LDL cholesterol will be. Cardiologist Abinash Achrekar, vice chair and professor in the ...

The researchers envisage that patients could have a yearly booster shot to top up their immunity. In mice, the treatment cuts LDL cholesterol by up to 50% over 12 months and appears to protect ...

Sanofi and Regeneron’s new cholesterol drug Praluent could be recommended for approval in Europe as early as this week, along with the world’s first malaria vaccine from GlaxoSmithKline.